Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1990 Feb;64(2):639–641. doi: 10.1128/jvi.64.2.639-641.1990

Reovirus type 3 binds to antagonist domains of the beta-adrenergic receptor.

S T Donta 1, J D Shanley 1
PMCID: PMC249154  PMID: 2153229

Abstract

Reovirus type 3 interfered with the binding of beta-adrenergic antagonist ligands to receptors on Y1 adrenal, C6 glioma, and mouse L cells. This inhibition of beta-adrenergic binding was dose related. Reovirus did not interfere with dopaminergic binding or isoproterenol-induced activation of adenylate cyclase. In addition, reovirus infected Y1 cells, which bind beta-adrenergic antagonist ligands but lack agonist-induced activity. These results suggest that reovirus infection is initiated by binding to antagonist (nonfunctional) domains of the adrenergic receptor complex.

Full text

PDF
639

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anhäupl T., Liebl B., Remien J. Kinetic and equilibrium studies of (-)125iodocyanopindolol binding to beta-adrenoceptors on human lymphocytes: evidence for the existence of two classes of binding sites. J Recept Res. 1988;8(1-4):47–57. doi: 10.3109/10799898809048977. [DOI] [PubMed] [Google Scholar]
  2. Bar R. S., Harrison L. C., Muggeo M., Gorden P., Kahn C. R., Roth J. Regulation of insulin receptors in normal and abnormal physiology in humans. Adv Intern Med. 1979;24:23–52. [PubMed] [Google Scholar]
  3. Choi A. H., Lee P. W. Does the beta-adrenergic receptor function as a reovirus receptor? Virology. 1988 Mar;163(1):191–197. doi: 10.1016/0042-6822(88)90246-2. [DOI] [PubMed] [Google Scholar]
  4. Co M. S., Gaulton G. N., Fields B. N., Greene M. I. Isolation and biochemical characterization of the mammalian reovirus type 3 cell-surface receptor. Proc Natl Acad Sci U S A. 1985 Mar;82(5):1494–1498. doi: 10.1073/pnas.82.5.1494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Co M. S., Gaulton G. N., Tominaga A., Homcy C. J., Fields B. N., Greene M. I. Structural similarities between the mammalian beta-adrenergic and reovirus type 3 receptors. Proc Natl Acad Sci U S A. 1985 Aug;82(16):5315–5318. doi: 10.1073/pnas.82.16.5315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dimmock N. J. Review article initial stages in infection with animal viruses. J Gen Virol. 1982 Mar;59(Pt 1):1–22. doi: 10.1099/0022-1317-59-1-1. [DOI] [PubMed] [Google Scholar]
  7. Donta S. T., Poindexter N. J., Ginsberg B. H. Comparison of the binding of cholera and Escherichia coli enterotoxins to Y1 adrenal cells. Biochemistry. 1982 Feb 16;21(4):660–664. doi: 10.1021/bi00533a011. [DOI] [PubMed] [Google Scholar]
  8. Donta S. T., Shanley J. D., Damiano-Burbach P. Encephalomyocarditis virus can bind to and transfect non-permissive cells. Arch Virol. 1986;88(3-4):301–307. doi: 10.1007/BF01310884. [DOI] [PubMed] [Google Scholar]
  9. Fingeroth J. D., Weis J. J., Tedder T. F., Strominger J. L., Biro P. A., Fearon D. T. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc Natl Acad Sci U S A. 1984 Jul;81(14):4510–4514. doi: 10.1073/pnas.81.14.4510. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gaulton G. N., Greene M. I. Inhibition of cellular DNA synthesis by reovirus occurs through a receptor-linked signaling pathway that is mimicked by antiidiotypic, antireceptor antibody. J Exp Med. 1989 Jan 1;169(1):197–211. doi: 10.1084/jem.169.1.197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gentsch J. R., Pacitti A. F. Differential interaction of reovirus type 3 with sialylated receptor components on animal cells. Virology. 1987 Nov;161(1):245–248. doi: 10.1016/0042-6822(87)90192-9. [DOI] [PubMed] [Google Scholar]
  12. Gentsch J. R., Pacitti A. F. Effect of neuraminidase treatment of cells and effect of soluble glycoproteins on type 3 reovirus attachment to murine L cells. J Virol. 1985 Nov;56(2):356–364. doi: 10.1128/jvi.56.2.356-364.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Graafsma S. J., van Tits L. J., Rodrigues de Miranda J. F., Thien T. Kinetics of (-)125iodocyanopindolol binding to intact human mononuclear cells. J Recept Res. 1988;8(6):773–785. doi: 10.3109/10799898809049025. [DOI] [PubMed] [Google Scholar]
  14. Kahn C. R. Membrane receptors for hormones and neurotransmitters. J Cell Biol. 1976 Aug;70(2 Pt 1):261–286. doi: 10.1083/jcb.70.2.261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  16. Liu J., Co M. S., Greene M. I. Reovirus type 3 and [125I]-iodocyanopindolol bind to distinct domains on the beta-adrenergic like receptor. Immunol Res. 1988;7(3):232–238. doi: 10.1007/BF02918138. [DOI] [PubMed] [Google Scholar]
  17. Nagata L., Masri S. A., Pon R. T., Lee P. W. Analysis of functional domains on reovirus cell attachment protein sigma 1 using cloned S1 gene deletion mutants. Virology. 1987 Sep;160(1):162–168. doi: 10.1016/0042-6822(87)90056-0. [DOI] [PubMed] [Google Scholar]
  18. Pacitti A. F., Gentsch J. R. Inhibition of reovirus type 3 binding to host cells by sialylated glycoproteins is mediated through the viral attachment protein. J Virol. 1987 May;61(5):1407–1415. doi: 10.1128/jvi.61.5.1407-1415.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Paul R. W., Lee P. W. Glycophorin is the reovirus receptor on human erythrocytes. Virology. 1987 Jul;159(1):94–101. doi: 10.1016/0042-6822(87)90351-5. [DOI] [PubMed] [Google Scholar]
  20. Pollet R. J., Levey G. S. Principles of membrane receptor physiology and their application to clinical medicine. Ann Intern Med. 1980 May;92(5):663–680. doi: 10.7326/0003-4819-92-5-663. [DOI] [PubMed] [Google Scholar]
  21. Sawutz D. G., Bassel-Duby R., Homcy C. J. High affinity binding of reovirus type 3 to cells that lack beta adrenergic receptor activity. Life Sci. 1987 Jan 26;40(4):399–406. doi: 10.1016/0024-3205(87)90142-1. [DOI] [PubMed] [Google Scholar]
  22. Shanley J. D., Lutwick L. I., Donta S. T. Replication of murine cytomegalovirus in murine Y-1 cells. J Med Virol. 1979;4(4):261–268. doi: 10.1002/jmv.1890040404. [DOI] [PubMed] [Google Scholar]
  23. Strickland S., Loeb J. N. Obligatory separation of hormone binding and biological response curves in systems dependent upon secondary mediators of hormone action. Proc Natl Acad Sci U S A. 1981 Mar;78(3):1366–1370. doi: 10.1073/pnas.78.3.1366. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Tomlinson G., Hnatowich M. R. Apparent competitive inhibition of radioligand binding to receptors: experimental and theoretical considerations in the analysis of equilibrium binding data. J Recept Res. 1988;8(6):809–830. doi: 10.3109/10799898809049027. [DOI] [PubMed] [Google Scholar]
  25. Verdin E. M., King G. L., Maratos-Flier E. Characterization of a common high-affinity receptor for reovirus serotypes 1 and 3 on endothelial cells. J Virol. 1989 Mar;63(3):1318–1325. doi: 10.1128/jvi.63.3.1318-1325.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Yeung M. C., Lim D., Duncan R., Shahrabadi M. S., Cashdollar L. W., Lee P. W. The cell attachment proteins of type 1 and type 3 reovirus are differentially susceptible to trypsin and chymotrypsin. Virology. 1989 May;170(1):62–70. doi: 10.1016/0042-6822(89)90352-8. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES